Position in ACAD
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$9,984,699
-$10,565,759 QoQ
Shares Held
448,549
-41.7% QoQ
Ownership
0.262%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 91.22169484270391.ToString("F0")%
Shared 0.ToString("F0")%
None 8.778305157296082.ToString("F0")%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Derivatives in ACAD
reported options exposure · as of Dec 31, 2021CallValue
$0
CallShares
0
PutValue
$210,060
PutShares
9,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. ACAD ranks #106 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in ACAD
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,984,699 | 448,549 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $20,550,458 | 769,392 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $14,187,812 | 664,846 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $15,880,329 | 736,223 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $17,554,278 | 1,056,850 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $22,777,395 | 1,241,275 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $9,291,856 | 604,152 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $7,402,703 | 455,551 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,358,359 | 343,881 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $9,623,409 | 307,359 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $3,015,464 | 144,696 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $3,345,838 | 139,701 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,883,053 | 153,191 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $5,847,717 | 367,319 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $835,553 | 51,073 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $476,269 | 33,802 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $1,536,346 | 63,433 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $210,060 | 9,000 | Put | Defined | 2022-02-14 | |
| 2021-12-31 | $5,109,311 | 218,908 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,612,724 | 217,503 | Shares | Defined | 2021-11-15 | |
| 2021-09-30 | $149,490 | 9,000 | Put | Defined | 2021-11-15 | |
| 2021-06-30 | $219,510 | 9,000 | Put | Defined | 2021-08-13 | |
| 2021-06-30 | $289,143 | 11,855 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $694,923 | 26,935 | Shares | Defined | 2021-05-12 | |
| 2021-03-31 | $232,200 | 9,000 | Put | Defined | 2021-05-12 | |
| 2020-12-31 | $2,066,817 | 38,661 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $1,253,092 | 30,378 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,183,976 | 24,427 | Shares | Defined | 2020-07-31 | |
| 2020-06-30 | $1,415,324 | 29,200 | Call | Defined | 2020-07-31 | |
| 2020-03-31 | $1,014,211 | 24,005 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||